“…The various factors responsible for variability among the population are genetic polymorphism Hruby and Anzenbacher, 1997;Board et al, 1998;Ozawa, 1998;Neber and Roe, 2001;Lamba et al, 2002;Miners et al, 2002;Nagar and Remmel, 2006;Hildebrandt et al, 2007), age (Wilkinson, 1997;Benedetti et al, 2007), gender (Shapiro et al, 1995;Gutmann et al, 2005), species (Hruby and Anzenbacher, 1997), strain (Chen et al, 2005;Wang et al, 2006;Joseph et al, 2007), diet and environmental factors (Wilkinson, 1997;Nowell et al, 1999;Huang and Lesko, 2004;Felton and Malfatti, 2006), induction and inhibition of drug-metabolizing enzymes Lin and Lu, 1998;Lu, 1998;Handschin and Meyer, 2003;Xu et al, 2005), and induction and inhibition of drug influx and efflux transporters (Suzuki and Sugiyama, 2000;Kim, 2002;Lau et al, 2004;Endres et al, 2006;Lin, 2007). Also, physiological conditions such as pregnancy (Larrey et al, 1986;Tsutsumi et al, 2001), pathological conditions or disease states (Wilkinson, 1997), route of administration (Assaf et al, 1975;Shand et al, 1975;Houston and Levy, 1976), dosing strength, and the dosage form can also impact drug-drug interactions. Induction and inhibition of the drug-metabolizing enzymes and efflux transporters by ligand-based NR activation are discus...…”